赵家军，主任医师，教授，现任山东第一医科大学副校长，山东省立医院院长，山东省临床医学研究院内分泌代谢研究所所长。山东省“泰山学者攀登计划”特聘专家。中华医学会内分泌学专业委员会主任委员，山东省医学会内分泌分会主任委员。山东省名医联盟主席。《中华内分泌代谢杂志》副总编。国家科学技术奖评审专家，国家自然科学基金委医学部内分泌组评审专家。发表论文500余篇，被Sci收录176篇（其中作为第一或通讯作者论文90余篇）。代表性论文发表在Cell
Res Hepatology、 Journal of Hepatology、Endocrinology、Thyroid、Journal of Clinical Endocrinology and Metabolism、Journal of Lipid Research等，其中2篇被F1000推荐。组织和参与编写诊疗指南和专家共识20余部。以第一完成人获国家科技进步二等奖2项，第18 届吴杨奖（临床医学领域），山东省科学技术最高奖，山东省自然科学奖一等奖1项，山东省科技进步一等奖4项、二等奖3项。研制的治疗甲状腺功能亢进症的“五岳抗甲丸”获2003年山东省专利发明奖，并实现转化。主持科技部“十一五”国家科技支撑计划1项，国家重点研发计划项目1项，国家自然基金重点项目1项，国家自然科学基金5项，其它省部级课题20余项。
Jiajun Zhao, the Vice president of Shandong First Medical University and the President of Provincial Hospital affiliated to Shandong First Medical University, the head of Institute of Endocrinology and Metabolism in Shandong Academy of Clinical Medicine, the director and professor of Department of Endocrinology and Metabolism,. He received his M.D. and Ph.D. fromShanghaiSecondMedicalUniversity. Dr. Zhao has been focusing on the study of endocrine and metabolic diseases, such as thyroid related disease, type 2 diabetes and insulin resistance syndrome, hereditary endocrine and metabolic diseases caused by single or multiple gene mutation, as well as the research on pathogenesis of endocrine related cancers. Dr. Zhao has received more than 10 grants and published more than 150 scientific papers in peer-reviewed journals. He is on the editorial boards of several journals and the chairman of the Chinese Endocrine Society, member of standing committee in the Chinese Integrated Traditional and Western Medicine Association.